ARTICLE | Distillery Therapeutics
ZDHHC7 and LYPLA2 identified as targets in Crohn’s, ulcerative colitis
October 27, 2020 7:55 PM UTC
DISEASE CATEGORY: Autoimmune disease
INDICATION: Inflammatory bowel disease (IBD); Crohn’s disease...
BCIQ Company Profiles
BCIQ Target Profiles